Having laid the groundwork for finding the AIDS virus, the headliner for the upcoming Fred Hutch HIV Cure conference talks about gene therapy for HIV and just what ‘cure’ means
Aug. 6, 2015
| By Mary Engel / Fred Hutch News Service
Nobel Laureate Dr. David Baltimore will be the keynote speaker at the 2015 Conference on Cell and Gene Therapy for HIV Cure held Aug. 13-14 at Fred Hutch. He will also take part in a community conversation about gene therapy for HIV/AIDS on the eve of the conference that is free and open to the public. To speak at an HIV cure conference held at a cancer research center is especially appropriate because Baltimore’s work in immunology and virology has profoundly influenced both HIV and cancer research, said Dr. Hans-Peter Kiem.
What a semi-nomadic ethnic group — and their performing monkeys — can teach us about how viruses jump from animals to humans
June 15, 2015
| By Dr. Rachel Tompa / Fred Hutch News Service
To understand how viruses leap from monkey to human, researchers at Fred Hutch and the University of Washington are studying the Bedey people, a semi-nomadic group that travels around Bangladesh, giving performances for cash with their trained monkeys.
Dr. Hans-Peter Kiem's award is part of $12 million multi-institution research collaboration to develop foamy virus gene replacement therapy for patients who suffer from Severe Combined Immunodeficiency
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.